Abstract
Neuropathic pain, or chronic pain due to nerve injury, is a prevalent condition for which currently there is no effective treatment. These neuropathic pain syndromes include deafferentation pain, diabetic, cancer and ischemic neuropathies, phantom limb pain, trigeminal neuralgia, postherpetic neuralgias and nerve injury caused by surgery or trauma [1]. Neuropathic pain is not only chronic and intractable, it is debilitating and causes extreme physical, psychological and social distress. In an effort to provide even temporary relief, narcotics (opioids) are often used inappropriately and in excess. Even if opioids provide some initial relief, tolerance and physical dependence are major limitations to their continued use. Clearly, development of non-opioid and non-addictive treatments for neuropathic pain would offer tremendous benefit to chronic pain patients. Our laboratory has focused on understanding mechanisms that lead to neuropathic pain. This knowledge may then translate into development of new, effective approaches for treatment and even prevention of chronic pain syndromes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Loeser JD. (1990) Peripheral nerve disorders (peripheral neuropathies). In: Bonica J (ed): The management of pain,. 2nd ed. Lea and Febiger, Pennsylvania, 211–219
DeLeo JA, Coombs DW (1991) Autotomy and decreased substance P following peripheral cryogenic nerve lesion. Cryobiol 28: 460–466
DeLeo JA, Coombs DW, Willenbring SW, Colburn RW, Fromm C, Wagner R, Twitchell BB (1994) Characterization of a neuropathic pain model: Sciatic cryoneurolysis in the rat. Pain 56: 9–16.
Willenbring S, DeLeo JA, Coombs DW (19 94) Differential behavioral outcomes in the sciatic cryoneurolysis model of neuropathic pain in rats. Pain 58: 135–140
Colburn RW, DeLeo JA, Rickman AJ, Yeager MP, Kwon P, Hickey WF (1997) Dissociation of microglial activation and neuropathic pain behaviors following peripheral nerve injury in the rat. J Neuroimmunol 79: 163–175
Colburn RW, DeLeo JA, Rickman AJ (1997) The effect of site vs. type of nerve injury on glial activation, spinal cytokine expression and behavior in the rat. Soc for Neurosci Abstr, New Orleans, LA
Bennett GJ, Xie YK (1988) A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33: 87–107
Kim SH, Chung JM (1992) An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50: 355–363
Woolf CJ, Allchorne A, Safieh-Garabedian B, Poole S (1997) Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor-a. Brit J Pharm 121: 417–424
Rothwell NJ (1991) Functions and mechanisms of interleukin-1 in the brain. Trends Pharmacol Sci 12: 430–436
Fontana A, Kristensen F, Dubs R, Gemsa D, Weber E (1992) Production of Joyce A. DeLeo and Raymond W. Colburn prostaglandin E and an interleukin-1 like factor by cultured astrocytes and C6 glioma cells. J Immunol 129: 2413–2419
Giulian D, Baker TJ, Shih L-CN, Lachman LB (1986) Interleukin-1 of the central nervous system is produced by ameboid microglia. J Exp Med 164: 594–604
Farrar WL, Hill JM, Harel-Bellan A, Vinocour M (1987) The immunological brain. Immunol Rev 100: 361–378
Lechan RM, Toni R, Clark BD, Cannon JG, Shaw AR, Dinarello CA, Reichlin S (1990) Immunoreactive interleukin-1(3 localization in the rat forebrain. Brain Res 514: 135–140
Sheeran P, Hall GM (1997) Cytokines in anaesthesia. Brit J Anaes 78: 201–219
Rotshenker S, Aamar S, and Barak V (1992) Interleukin-1 activity in lesioned peripheral nerve. J Neuroimmunol 39: 75–80
Watkins LR, Wiertelak EP, Goehler LE, Smith KP, Martin D, Maier SF (1994) Characterization of cytokine-induced hyperalgesia. Brain Res 654: 15–26
Oka T, Aou S, Hori T (1993) Intracerebroventricular injection of interleukin-1(3 induces hyperalgesia in rats. Brain Res 624: 61–68
Oka T, Aou S, Hori T (1994) Intracerebroventricular injection of interleukin-113 enhances nociceptive neuronal responses of trigeminal nucleus caudalis in rats. Brain Res 656: 236–244
Oka T, Oka K, Hosoi M, Aou S, Hori T (1995) The opposing effects of interleukin-113 microinjected into the preoptic hypothalamus on nociceptive behavior in rats. Brain Res 700: 271–278
Won C, Park HJ, Shin HC (1995) Interleukin-113 facilitates afferent sensory transmission in the primary somatosensory cortex of anesthestized rats. Neurosci Letters 201: 255–258
Patterson PH, Nawa H (1993) Neuronal differentiation factors/cytokines and synaptic plasticity. Cell 72: 123–137
Taga T (1996) gp130, a shared signal transducing receptor component for hematopoietic and neuropoietic cytokines. J Neurochem 67: 1–10
Kiefer R, Lindholm, D, Kreutzberg, G (1993) Interleukin-6 and transforming growth factor-131 mRNAs are induced in rat facial nucleus following motorneuron axotomy. Eur J Neurosci 5: 775–781
Murphy PG, Grodin J, Altares M, Richardson PM (1995) Induction of interleukin-6 in axotomized sensory neurons. J Neurosci 15: 5130–5138
Bolin LM, Verity AN, Silver JE, Shooter EM, Abrams JS (1995) Interleukin-6 production in schwann cells and induction in sciatic nerve injury. J Neurochem 64: 850–858
Frei K, Malipiero UV, Leist TP, Zinkernagel RM, Schwab ME, Fontana A (1989) On the cellular source and function of interleukin-6 produced by the central nervous system. Eur J Immunol 19: 689–694
Le J, Vilcek J (1989) Interleukin-6: a multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab Invest 61: 588–602
Fattori E, Lazzaro D, Musiani P, Modesti A, Alonzi T, Ciliberto G (1995) IL-6 expres-sion in neurons of transgenic mice causes reactive astrocytosis and increase ramified microglial cells but no neuronal damage. Eur J Neurosci 7: 2441–2449
DeLeo JA and RW Colburn (1996) The role of cytokines in nociception and chronic pain. In: Weinstein J, Gordon S (eds): Low back pain: A scientific and clinical overview. American Academy of Orthopaedic Surgeons, Illinois, 163–186
Oka T, Oka K, Hosoi M, Hori T (1995) Intracerebroventricular injection of interleukin6 induces thermal hyperalgesia in rats. Brain Res 692: 123–128
DeLeo JA, Colburn RW, Nichols M, Malhotra A (1996) Interleukin (IL)-6 mediated hyperalgesia/alloydnia and increased spinal IL-6 in a mononeuropathy model in the rat. J Interferon and Cytokine Res 16: 695–700
Qui Z, Parson KL, Gruol DL (1995) Interleukin-6 selectively enhances the intracellular calcium response to NMDA in developing CNS neurons. J Neurosci 15: 6688–6699
Meller ST, Gebhart GF (1993) Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 52: 127–136
Davar G, Jama A, Deykin A, Vos B, Maciewicz R (1991) MK-801 blocks the development of thermal hyperalgesia in a rat model of experimental painful neuropathy. Brain Res 553: 327–330
Price DD, Mao J, Frenk H, Mayer DJ (1994) The N-methyl-D-aspartate receptor antagonist dextromethorphan selectively reduces temporal summation of second pain in man. Pain 59: 165–174.
Beutler B, Greenwald D, Hulmes JD, Chang M, Pan YC, Mathison J, Ulevitch R, Cera-mi A (1985) Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Nature 316: 552–554
Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B (1975) An endotoxininduced serum factor that causes necrosis of tumors. Proc Natl Acad Sci 72: 3666–3669
Tsujimoto M, Vilcek J (1986) Tumor necrosis factor receptors in HeLa cells and their regulation by interferon-gamma. J Biol Chem 261: 5384–5388
Smith CA, Davis T, Anderson D (1990) A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248: 1019–1023
Loetscher H, Pan YC, Lahm HW (1990) Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell 61: 351–359
Englemann H, Aderka D, Rubinstein M, Rotman D, Wallach D (1989) A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity. J Biol Chem 264: 11974–11980
Olsson I, Lantz M, Nilsson E (1989) Isolation and characterization of a tumor necrosis factor binding protein from urine. Eur J Haematol 42: 270–275
Moreland LW, Baumgartner SW, Schiff MH, Tindall EA, Fleischmann RM, Weaver AL, Ettlinger RE, Cohen S, Koopman WJ, Mohler K et al (1997) Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. New Eng J Med 337: 141–147
Koller H, Thiem K, Siebler M (1996) Tumour necrosis factor-a increases intracellular Ca2+ and induces a depolarization in cultured astroglial cells. Brain 119: 2021–2027
Fine SM, Angel RA, Perry SW, Epstein LF, Rothstein JD, Dewhurst S, Gelbard HA (1996) Tumor necrosis factor-a inhibits glutamate uptake by primary human astrocytes. J Biol Chem 271(26): 15303–15306
Ding M, Hart RP, Jonakait FM (1995) Tumor necrosis factor-a induces substance P in sympathetic ganglia through sequential induction of Interleukin-1 and Leukemia Inhibitory Factor. J Neurobiol 28: 445–454
DeLeo JA, Colburn RW, Rickman AJ (1997) Cytokine and growth factor immunohistochemical spinal profiles in two animal models of mononeuropathy. Brain Res 759: 50–57
Hickey, WF, Kimura H (1988) Perivascular microglia are bone marrow derived and present antigen in vivo. Science 239: 290–292
Streit WJ, and Kincaid-Colton CA (1995) The brain’s immune system. Scientific Amer Nov: 54–61
Meller ST, Dykstra C, Grsybicki, Murphy S, Gebhart GF (1994) The possible role of glia in nociceptive processing and hyperalgesia in the spinal cord of the rat. Neuropharm 33: 1471–1478
Garrison CJ, Dougherty PM, Kajander KC, Carlton SM (1991) Staining of glial fibrillary acidic protein (GFAP) in lumbar spinal cord increases following a sciatic nerve constriction injury. Brain Res 565: 1–7
Hajos F, Csillik B, Knyihar-Csillik E (1990) Alterations in glial fibrillary acidic protein immunoreactivity in the upper dorsal horn of the rat spinal cord in the course of trans-ganglionic atrophy and regenerative proliferation. Neurosci Lett 17: 8–13
Tetzlaff W, Graeber MB, Bisby MA, Kreutzberg GW (1988) Increased glial fibrillary protein synthesis in astrocytes during retrograde reaction of the rat facial nucleus. Glia 1: 90–95
Norris JG, Benveniste EN (1993) Interleukin-6 production by astrocytes: Induction by the neurotransmitter norepinephrine. J Neurosci 45:137–146
Chung JM, Leem JW, Kim SH (1992) Somatic afferent fibers which continuously discharge after being isolated from their receptors. Brain Res 599: 29–33
Korenman EMD, Devor M (1981) Ectopic adrenergic sensitivity in damaged peripheral nerve axons in the rat. Exp Neurol 72: 63–81.
McLachlan EM, Janig W, Devor M, Michaelis M (1993) Peripheral nerve injury triggers noradrenergic sprouting within the dorsal root ganglia. Nature 363: 543–545
Sato J, Perl ER (1993) Adrenergic excitation of cutaneous pain receptors induced by peripheral nerve injury. Science 251:1608–1610
Ventimiglia R, Green MI, Geller HM (1987) Localization of f3-adrenergic receptors on differentiated cells of the central nervous system in culture. Proc Natl Acad Sci 84: 5073–5077
Furukawa S, Furukawa Y, Satoyoshi E, Hayashi K (1987) Regulation of nerve growth factor synthesis/secretion by catecholamine in cultured mouse astroglial cells. Biochem Biophys Res Commun 147: 1048–1054
Frohman EM, Vayuvegula B, van den Noort S, Gupta S (1988) Norepinephrine inhibits gamma-interferon-induced MHC class II (Ia) antigen expression on cultured brain astrocytes. J Neuroimmunol 17: 89–101
Kashiba H, Senba E, Kawai Y, Ueda Y, Tohyama (1992) Axonal blockade induces the expression of vasoactive intestinal peptide and galanin in rat dorsal root ganglion neurons. Brain Res 577: 19–28
Sontheimer H, Black JA, Waxman SG (1996) Voltage-gated Na+ channels in glia: properties and possible functions. Trends Neurosci 19: 325–331
Steinhauser C, Gallo V (1996) News on glutamate receptors in glial cells. Trends Neurosci 19: 339–345
Glabinshi AR, Balasingam V, Tani M, Kunket SL, Strieter RM, Yong VW, Ransohoff RM (1996) Chemokine monocyte chemoattractant protein-1 is expressed by astrocytes after mechanical injury to the brain. J Immunol 156: 4363–4368
Hurwitz AA, Lyman WD, Berman JW (1995) Tumor necrosis factor alpha and transforming growth factor beta upregulate astrocyte expression of monocyte chemoattractant protein-1. J Neuroimmunol 57: 193–198
Garrison CJ, Dougherty PM, Carlton SM (1994) GFAP expression in lumbar spinal cord of naive and neuropathic rats treated with MK-801. Exp Neurol 129: 237–243
Watkins LR, Marin D, Ulrich P, Tracey KJ, Maier SF (1997) Evidence for the involvement of spinal cord glia in subcutaneous formalin induced hyperalgesia in the rat. Pain 71: 225–235
Xiao WH, Wagner R, Myers RR, Sorkin LS (1996) TNF-a applied to the sciatic nerve trunk elicits background firing in nociceptive primary afferent fibers. 8th World Congress on Pain. Vancouver, BC, Canada
Wagner R, Myers RR (1996) Endoneurial injection of TNF alpha produces neuropathic behaviors. Neuro Report 7: 2897–2901
Bennett GJ, Laird JMA (1992) Central changes contributing to neuropathic hyperalgesia. In: Willis, Jr. WD (ed): Hyperalgesia and allodynia. Raven Press, New York, 305–310
Wagner R, DeLeo JA, Coombs DW, Colburn RW, Willenbring S, Fromm C (1993) Spinal dynorphin bilaterally increases in a rat neuropathic pain model. Brain Res 629: 323–326
Wall PD (1983) Alterations in the central nervous system after deafferentation: Connectivity control. In: Bonica J (ed): Advances in pain research and therapy. Raven Press, New York, 677–689
Lewin GR, Rueff A, Mendell LM (1994) Peripheral and central mechanisms of NGFinduced hyperalgesia. Eur J Neurosci 6: 1903–1912
Strijbos P, Rothwell NJ (1995) Interleukin-43 attenuates excitatory amino acid-induced neurodegeneration in vitro: involvement of nerve growth factor. J Neurosci 15: 3468–3474
Lewin GR, Mendell LM (1993) Nerve growth factor and nociception. TINS 16: 353–365
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Basel AG
About this chapter
Cite this chapter
DeLeo, J.A., Colburn, R.W. (1999). Proinflammatory cytokines and glial cells: Their role in neuropathic pain. In: Watkins, L.R., Maier, S.F. (eds) Cytokines and Pain. Progress in Inflammation Research. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8749-6_7
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8749-6_7
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9756-3
Online ISBN: 978-3-0348-8749-6
eBook Packages: Springer Book Archive